Penn State Children's Hospital
Calendar  I  Contact Us  I  Help  I  Search
 
  1-800-243-1455
 

 

 

Health & Disease Information

 
 

A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P  Q   R   S   T   U   V   W   X   Y   Z

 
 

Penn State Endocrinology


Growth Hormone Deficiency

Also known as:  hypopituitarism

What is it?

Growth hormone deficiency (GHD), also known as hypopituitarism, occurs in children who have a deficient pituitary gland that secrets inadequate amount of growth hormone. Growth hormone is usually secreted in response to sleep, exercise, and hypoglycemia and promotes growth and metabolic function.

Who gets it?

It is estimated that GHD affects 1 in every 4,000 school-age children. GHD occurs three or four times more often among boys than girls.

What causes it?

Causes of GHD include hypothalamic disorders that impair secretion of growth hormone, and lesions of the pituitary gland or pituitary stalk that cause deficiencies. In some cases it is found that children diagnosed with GHD have developmental defects of the pituitary gland and hypothalamus, which can be inherited. In addition, 65% of children who have received radiation therapy for such diseases as leukemia or middle-ear or nasopharyngeal tumors have deficiencies in growth hormone. GHD can also occur among children with emotional disturbances caused by living in hostile and inadequate living environments.

What are the symptoms?

GHD is characterized by a decrease in growth, delay in skeletal maturation and absence of other explanations for poor growth. Infants with intrauterine GHD at birth can have hypoglycemic seizures and prolonged jaundice; boys have micropenis and undescended testes. Growth failure is often is apparent by the end of the first year, and growth rates continue to slow during childhood. Children with GHD are normally proportioned for age, have a prominent skullcap, tend to be overweight for height, and have prominent deposits of abdominal fat. Many affected patients do not undergo puberty at the appropriate age because of GHD.

How is it diagnosed?

Children suffering from growth failure are typically diagnosed by the end of the first year after birth. To diagnose GHD, previous growth measurements are evaluated, a bone age (x-ray of a child's hand and wrist) is taken and blood samples are assessed for possible thyroid hormone deficiency. Testing for GHD will occur when other possibilities of short stature have been ruled out. A child's growth hormone secretion will be stimulated and measured over a period of 8-12 hours, since growth hormone secretion varies throughout the day and is greatest after falling asleep.

What is the treatment?

Once diagnosed with GHD, the patient will be treated with human growth hormone. Though every child may not react similarly to growth hormone treatment, the majority of children treated appropriately will reach genetically expected adult heights. Growth hormone therapy is given by injection, either daily or several times per week, by parents who are trained to give these injections.

Self-care tips

Early diagnosis of GHD is extremely important for the affected child. To obtain the best results, a child must be diagnosed and treated at a relatively young age. Successful treatment must begin before the child's bones fuse; once fusing has taken place, no additional growth is possible. Many children much shorter than their peers experience both physical and emotional problems. Communicate with your child, offer assistance when necessary, and remember to treat the child according to their age, not their size.


This information has been designed as a comprehensive and quick reference guide written by our health care reviewers.  The health information written by our authors is intended to be a supplement to the care provided by your physician.  It is not intended nor implied to be a substitute for professional medical advice.

Back

 
   



Penn State Milton S. Hershey Medical Center ©2004
This page was last updated on October 31, 2006
Contact Us